What's New in the Management of Bacterial Septic Arthritis?
Overview
Authors
Affiliations
Septic arthritis is a common rheumatological emergency requiring prompt diagnosis and treatment, since delays in management can lead to high morbidity and mortality. In this review article, we discuss the epidemiology and recent advances in knowledge of the pathogenesis of septic arthritis, with a special emphasis on various bacterial and host factors involved in mediating the inflammatory process and the potential for targeted therapy to modulate the immune response. Recent advances in laboratory and imaging techniques are reviewed along with treatment and potential new therapies.
Pilot study of a novel serum mRNA gene panel for diagnosis of acute septic arthritis.
Schultz B, Sweeney T, DeBaun M, Remmel M, Midic U, Khatri P World J Orthop. 2020; 10(12):424-433.
PMID: 31908991 PMC: 6937427. DOI: 10.5312/wjo.v10.i12.424.
Neutrophils: Beneficial and Harmful Cells in Septic Arthritis.
Boff D, Crijns H, Teixeira M, Amaral F, Proost P Int J Mol Sci. 2018; 19(2).
PMID: 29401737 PMC: 5855690. DOI: 10.3390/ijms19020468.
Loock J, Haustedt N, Wollenhaupt J Z Rheumatol. 2014; 73(7):623-33.
PMID: 25115141 DOI: 10.1007/s00393-014-1463-3.